PATENT CLAIM ANALYSIS

Application Number: 16050155
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "171000"]

Abstract:
This invention relates the use of cortisol blockers (glucocorticoid receptor [GR] antagonists) for the treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.

Claim (Index 7):
The method of  claim 4  wherein the at least one glucocorticoid receptor antagonist is in a pharmaceutical preparation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 95.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15854053', '15471123', '13364651', '14982139', '15095293']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8326398929755592
- 35 USC 102 Novelty (BERT): 0.5937695742471354
- Combined Prediction Score: 0.8087528611027168
- Mean Citation Score: 544.0131
- Max Citation Score: 592.3739
- Similarity Product: 397.141952834034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test